<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28977203</article-id><article-id pub-id-type="pmc">5613727</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Noninvasive Ventilation During Immediate Postoperative Period in
Cardiac Surgery Patients: Systematic Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pieczkoski</surname><given-names>Suzimara Monteiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Margarites</surname><given-names>Ane Glauce Freitas</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sbruzzi</surname><given-names>Graciele</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="c1"/></contrib></contrib-group><aff id="aff1">
<label>1</label> Multi-Professional Integrated Residency in Health and
Cardiovascular Care of the Hospital de Cl&#x000ed;nicas of Porto Alegre (HCPA), Porto
Alegre, RS, Brazil.</aff><aff id="aff2">
<label>2</label> Hospital de Cl&#x000ed;nicas of Porto Alegre (HCPA), Porto Alegre,
RS, Brazil.</aff><aff id="aff3">
<label>3</label> Universidade Federal do Rio Grande do Sul (UFGRS), Porto Alegre,
RS, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Graciele Sbruzzi, Rua Felizardo, 750 -
Bairro Jardim Bot&#x000e2;nico - Porto Alegre, RS, Brazil - Zip code: 90690-200.
Email: <email>gsbruzzi@hcpa.edu.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2017</year></pub-date><volume>32</volume><issue>4</issue><fpage>301</fpage><lpage>311</lpage><history><date date-type="received"><day>20</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>3</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To verify the effectiveness of noninvasive ventilation compared to
conventional physiotherapy or oxygen therapy in the mortality rate and
prevention of pulmonary complications in patients during the immediate
postoperative period of cardiac surgery.</p></sec><sec><title>Methods</title><p>Systematic review and meta-analysis recorded in the International Prospective
Register of Ongoing Systematic Reviews (number CRD42016036441). The research
included the following databases: MEDLINE, Cochrane Central, PEDro, LILACS
and manual search of the references of studies published until March 2016.
The review included randomized controlled trials with patients during the
immediate postoperative period of cardiac surgery, which compared the use of
noninvasive ventilation, BiLevel modes, continuous positive airway pressure,
intermittent positive pressure breathing and positive pressure ventilation
with conventional physiotherapy or oxygen therapy, and assessed the
mortality rate, occurrence of pulmonary complications (atelectasis,
pneumonia, acute respiratory failure, hypoxemia), reintubation rate,
ventilation time, time spent in the intensive care unit (ICU), length of
hospital stay and partial pressure of oxygen.</p></sec><sec><title>Results</title><p>Among the 479 selected articles, ten were included in the systematic review
(n=1050 patients) and six in the meta-analysis. The use of noninvasive
ventilation did not significantly reduce the risk for atelectasis (RR: 0.60;
CI95% 0.28-1.28); pneumonia (RR: 0.20; CI95% 0.04-1.16), reintubation rate
(RR: 0.51; CI95%: 0.15-1.66), and time spent in the ICU (-0.04 days; CI95%:
-0.13; 0.05).</p></sec><sec><title>Conclusion</title><p>Prophylactic noninvasive ventilation did not significantly reduce the
occurrence of pulmonary complications such as atelectasis, pneumonia,
reintubation rate and time spent in the ICU. The use is still unproven and
new randomized controlled trials should be carried out.</p></sec></abstract><kwd-group><kwd>Thoracic Surgery</kwd><kwd>Cardiovascular Surgical Procedures</kwd><kwd>Noninvasive Ventilation</kwd><kwd>Meta-Analysis</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="38%" span="1"/><col width="4%" span="1"/><col width="10%" span="1"/><col width="38%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ARF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute respiratory
failure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Incentive
spirometer</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NIV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Noninvasive
ventilation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Conventional
physiotherapy</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PaO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Partial pressure of
oxygen</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPAP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Continuous positive
airway pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Postoperative</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PSV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Positive pressure
ventilation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RCTs</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Randomized controlled
trials</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IPPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intermittent positive
pressure breathing</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Patients in the postoperative (PO) period of cardiac surgery have greater risk to
develop pulmonary complications. These complications can increase hospitalization
time, morbidity, mortality, and costs for the health system<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Among the most frequent pulmonary
complications are atelectasis, pneumonia, pulmonary edema and acute respiratory
failure (ARF). Atelectasis is one of the most common<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The etiology of pulmonary complications results from a multifactorial process.
Surgical factors such as the use of cardiopulmonary bypass (CPB), anesthesia,
surgery time, mechanical ventilation time, pleural opening, phrenic nerve
alteration, use of the mammary artery in myocardial revascularization surgery, pain
in the sternal surgical wound and in the surgical drains lead to a decrease in the
functional residual capacity and increase of intrapulmonary shunt<sup>[<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In addition, preoperative factors regarding the patient, such
as previously existing lung diseases, smoking, old age, poor nutritional health,
among others, are a predisposition to complications<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Certain measures are used during the PO of cardiac surgeries, in an attempt to
minimize pulmonary complications, such as adequate analgesia, oxygen therapy and
physiotherapy. The physiotherapist uses the resources and chest physiotherapy
techniques, such as deep breathing stimulation, cough stimulation, use of incentive
spirometers, early patient mobilization and ambulation<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r8" ref-type="bibr">8</xref>]</sup>. However,
sometimes these features and techniques are not enough, and additional measures,
such as the use of noninvasive ventilation (NIV), are necessary.</p><p>NIV is a support for spontaneous ventilation with portable ventilators. Its use as a
prophylactic measure aims to reduce the incidence of endotracheal intubation, length
of hospital stay and prevent pulmonary complications<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>. However,
even with randomized controlled trials (RCTs) and a systematic review, there is no
consensus in the literature regarding its use as a prophylactic measure after
cardiac surgery.</p><p>Zarbock et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> carried out a
study with 468 elective heart surgery patients during the period of postoperative
care and showed that the use of prophylactic continuous positive airway pressure
(CPAP) reduced the incidence of pulmonary complications such as hypoxemia,
pneumonia, reintubation rate, and reduced the readmission rate in intensive care,
compared to the control group. However, another study with 30 patients undergoing
coronary artery bypass grafting (CABG) showed that CPAP therapy minimized the
decrease in partial pressure of oxygen (PaO<sub>2</sub>) after extubation, however,
it was unable to prevent the decrease of oxygenation on the second PO day<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. In 2011, a systematic review
investigated the use of NIV as a preventive measure in patients undergoing heart
surgery, including four studies. The authors found that NIV, compared to standard
treatment with oxygen therapy and chest physiotherapy, significantly improved gas
exchange without any significant difference in the rate of atelectasis<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>Thus, the existence of new RCTs related to the prophylactic use of NIV in patients
during the immediate PO period of cardiac surgery, and the absence of meta-analysis,
justify a systematic review with a recent meta-analysis on the subject. Thus, the
objective of this review is to verify the effectiveness of the use of NIV compared
to conventional physiotherapy (CP) or oxygen therapy in the mortality rate and
prevention of pulmonary complications in patients in the immediate PO of cardiac
surgery.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This is a systematic review and meta-analysis of RCTs, registered with the
International Prospective Register of Ongoing Systematic Reviews (PROSPERO) under
the number CRD42016036441, and following the recommendations of the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA
Statement<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> and the
Cochrane Collaboration<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.</p><sec><title>Eligibility Criteria</title><p>The review included RCTs with patients during the immediate PO period of heart
surgery (CABG, valve replacement, among others) that compared the use of NIV,
BiLevel, CPAP, intermittent positive pressure breathing (IPPB) and positive
pressure ventilation (PSV) with CP or oxygen therapy. And also, that assessed
mortality rate and incidence of pulmonary complications (atelectasis, pneumonia,
ARF, hypoxemia) as primary outcomes, and reintubation rate, ventilation time,
time spent in the intensive care unit (ICU), length of hospital stay and
PaO<sub>2</sub> as secondary outcomes. Studies that included patients in the
PO period of other types of surgery, and patients who were heart transplant
recipients, were excluded from the review.</p></sec><sec><title>Search Strategy</title><p>The studies were found using a systematic search in the databases MEDLINE (via
PubMed), Cochrane Central, PEDro, LILACS, in addition to a manual search of the
references of published studies on the subject. There was no restriction of date
and language for this research. The search included studies published from the
start of the databases until March, 2016, and comprised the key descriptors and
synonyms terms referring to "cardiac surgery", "coronary artery bypass",
"tricuspid valve replacement", "mitral valve replacement", "aortic valve
replacement", "noninvasive ventilation", "continuous positive airway pressure",
and "positive-pressure respiration", combined with a sensitive list of ECR
search terms developed by Robinson &#x00026; Dickersin<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. The complete search strategy used for PubMed
is shown on <xref ref-type="table" rid="t1">Table 1</xref>. Other strategies
will be available upon request.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Research strategy used on PubMed.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">#1</td><td align="left" valign="top" rowspan="1" colspan="1">"Cardiac Surgery"[MeSH] OR "Cardiac
Surgery" OR "Surgery, Thoracic" OR "Surgery, Cardiac" OR
"Surgery, Heart" OR "Heart Surgery" OR "Procedure, Cardiac
Surgical" OR "Procedures, Cardiac Surgical" OR "Surgical
Procedure, Cardiac" OR "Surgical Procedures, Cardiac" OR
"Surgical Procedures, Heart" OR "Cardiac Surgical Procedure" OR
"Heart Surgical Procedures" OR "Procedure, Heart Surgical" OR
"Procedures, Heart Surgical" OR "Surgical Procedure, Heart" OR
"Heart Surgical Procedure"</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#2</td><td align="left" valign="top" rowspan="1" colspan="1">"Coronary Artery Bypass"[Mesh] OR
"Coronary Artery Bypass" OR "Artery Bypass, Coronary" OR "Artery
Bypasses, Coronary" OR "Bypasses, Coronary Artery" OR "Coronary
Artery Bypasses" OR "Coronary Artery Bypass Surgery" OR "Bypass,
Coronary Artery" OR "Aortocoronary Bypass" OR "Aortocoronary
Bypasses" OR "Bypass, Aortocoronary" OR "Bypasses,
Aortocoronary" OR "Bypass Surgery, Coronary Artery" OR "Coronary
Artery Bypass Grafting"</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#3</td><td align="left" valign="top" rowspan="1" colspan="1">"Tricuspid Valve Replacement" OR
"Tricuspid Valve Surgery" OR "Valve&#x000a0;&#x000a0;&#x000a0;&#x000a0; Replacement" OR "Valve
Surgery" OR "Mitral Valve Replacement" OR "Mitral Valve Surgery"
OR "Aortic Valve Replacement" OR "Aortic Valve Surgery"</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#4&#x000a0;&#x000a0;&#x000a0;</td><td align="left" valign="top" rowspan="1" colspan="1">#1 OR #2 OR #3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#5</td><td align="left" valign="top" rowspan="1" colspan="1">"Noninvasive ventilation"[MeSH] OR
"Noninvasive Ventilation" OR&#x000a0; "Noninvasive Ventilations" OR
"Ventilation, Noninvasive" OR "Ventilations,&#x000a0;&#x000a0;&#x000a0;&#x000a0; Noninvasive" OR
"Non-Invasive Ventilation" OR "Non-Invasive Ventilations"&#x000a0;&#x000a0; OR
"Ventilation, Non-Invasive" OR "Ventilations, Non-Invasive" OR
"Non&#x000a0; &#x000a0;Invasive Ventilation" OR "Non Invasive Ventilations" OR
"Ventilation, Non Invasive" OR "Ventilations, Non Invasive" OR
"bilevel ventilation" OR&#x000a0; "Noninvasive Positive Pressure
Ventilation" OR "CPAP" OR "BIPAP"</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;#6</td><td align="left" valign="top" rowspan="1" colspan="1">"Continuous Positive Airway
Pressure"[Mesh] OR "Continuous Positive&#x000a0; Airway Pressure" OR
"CPAP Ventilation" OR "Ventilation, CPAP" OR "Biphasic
Continuous Positive Airway Pressure" OR "Bilevel Continuous
Positive Airway Pressure" OR "Nasal Continuous Positive Airway
Pressure" OR "Ncpap Ventilation" OR "Ventilation, ncpap"</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#7&#x000a0;</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;"Positive-Pressure Respiration"[Mesh]
OR "Positive-Pressure Respiration</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#8&#x000a0;&#x000a0;</td><td align="left" valign="top" rowspan="1" colspan="1">#5 OR #6 OR #7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#9&#x000a0;</td><td align="left" valign="top" rowspan="1" colspan="1">(randomized controlled trial[pt] OR
controlled clinical trial[pt] OR randomized controlled
trials[mh] OR random allocation[mh] OR double-blind method[mh]
OR single-blind method[mh] OR clinical trial[pt] OR clinical
trials[mh] OR ("clinical trial"[tw]) OR ((single*[tw] OR
double*[tw] OR OR triple*[tw]) AND (mask*[tw] OR blind*[tw])) OR
("latin square"[tw]) OR placebos[mh] OR placebo*[tw] OR
random*[tw] OR research design[mh:noexp] OR follow-up
studies[mh] OR prospective studies[mh] OR cross-over studies[mh]
OR control*[tw] OR prospective*[tw] OR volunteer*[tw]) NOT
(animal[mh] NOT human[mh])</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">#10</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;#4 AND #8 AND #9</td></tr></tbody></table></table-wrap></sec><sec><title>Study Selection</title><p>Two assessors (S.M.P and A.F.M) independently analyzed the titles and abstracts
of the articles identified by the search strategy, strictly adhering to the
inclusion and exclusion criteria. Articles that did not provide enough
information in the titles and abstracts, were fully read by the same assessors,
independently. The selection was made following the eligibility criteria.
Disagreements over the inclusion of the studies were resolved by consensus among
the assessors.</p></sec><sec><title>Data Extraction</title><p>The data extraction was performed independently by the same two assessors, using
a standardized form. Information on patient characteristics, intervention,
outcomes, and methodological quality were extracted. Disagreements were resolved
by consensus. The main outcomes were mortality rate and incidence of pulmonary
complications (atelectasis, pneumonia, ARF, hypoxemia) and the secondary
outcomes were reintubation rate, ventilation time (hours), time spent in the
ICU, length of hospital stay (days), and PaO<sub>2</sub>.</p></sec><sec><title>Risk of Bias Assessment</title><p>The methodological quality was evaluated independently by the same two assessors,
in a descriptive manner, based on the recommendations of the Cochrane
Collaboration<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The
following items were evaluated: random sequence generation, allocation
concealment, patient blinding, blinding of therapists and outcome assessors,
intention-to-treat analysis, and description of losses and exclusions. These
characteristics were considered as "not informed" in studies without clear
description of them.</p></sec><sec><title>Data Analysis</title><p>The data analysis was performed in a descriptive and quantitative manner.
Regarding the categorical outcomes, relative risk and 95% confidence intervals
were calculated using the random effect model (Mantel-Haenszel) according to the
number of events reported in the intention-to-treat analysis of the original
studies. For the continuous outcomes, the effect estimations were obtained by
the difference between the averages and their standard deviations, with 95%
confidence intervals using the random effect model. The statistical
heterogeneity of the treatment effects between studies was assessed using the
I-square inconsistency test, where values above 25% and 50% were considered as
indicative of moderate and high heterogeneity, respectively. All analyses were
carried out using the Review Manager software, version 5.3 (Cochrane
Collaboration).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Description of the Studies</title><p>Four hundred and seventy-nine articles were identified with the search strategy,
of which 21 studies were considered for detailed analysis. After the analysis,
ten articles met the eligibility criteria and were included in this review, with
a total of 1050 patients. Among these studies, three used the BiLevel
mode<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>,
four the CPAP<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>, one the
BiLevel mode and CPAP in the same study<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, one the IPPB<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> and one the PSV<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Regarding the control groups, seven
studies<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r19" ref-type="bibr">19</xref>]</sup> performed
CP. Of these, one performed only CP<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>; the other used CP associated with incentive
spirometer (IS)<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>, standard treatment (oxygen
therapy and CPAP for some patients, pharmacological treatment)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, usual care (pharmacological
measures and IS)<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> and
oxygen therapy<sup>[<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Two studies<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup> received oxygen therapy exclusively and one of the
studies<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> did not
clearly describe the comparison. <xref ref-type="fig" rid="f1">Figure 1</xref>
shows the flowchart of the included studies and <xref ref-type="table" rid="t2">Table 2</xref> the characteristics of these studies.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart of the studies included in the systematic review and
meta-analysis. NIV=noninvasive ventilation. PO=postoperative </p></caption><graphic xlink:href="rbccv-32-04-0301-g01"/></fig></p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of the studies included in the review.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">Study, year</th><th align="center" valign="top" rowspan="1" colspan="1">Type of surgery</th><th align="center" valign="top" rowspan="1" colspan="1">Participants (N - I/C)</th><th align="center" valign="top" rowspan="1" colspan="1">Intervention vs. control groups</th><th align="center" valign="top" rowspan="1" colspan="1">Intervention group</th><th align="center" valign="top" rowspan="1" colspan="1">Control group</th><th align="center" valign="top" rowspan="1" colspan="1">Assessed outcomes</th><th align="center" valign="top" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Al Jaaly et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, 2013</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">126 - 63/63</td><td align="left" valign="top" rowspan="1" colspan="1">BiLevel+ usual care<sup>a</sup>,
<italic>vs.</italic> usual care<sup>a</sup>+ CPAP for six
patients who needed ventilation support</td><td align="left" valign="top" rowspan="1" colspan="1">Stratified by BMI: BMI&#x0003c;30: IPAP 12
cmH<sub>2</sub>O, EPAP 5 cmH<sub>2</sub>O; BMI&#x02265;30:
IPAP 17, EPAP 10 cmH<sub>2</sub>O; for 24h (removed so the
patient could eat, or before if they could not tolerate it)</td><td align="left" valign="top" rowspan="1" colspan="1">2x/day on the first two to three days
after surgery</td><td align="left" valign="top" rowspan="1" colspan="1">Mortality rate Atelectasis Pneumonia
Reintubation rate MV Time Time spent in the ICU Length of
hospital stay until release</td><td align="left" valign="top" rowspan="1" colspan="1">Mortality rate: the same in both
groups<break/> Atelectasis, pneumonia and Reintubation rate:
less frequent in the intervention group<break/> MV Time: similar
between groups (without statistically significant data)<break/>
Time spent in the ICU: shorter in the intervention group, but
without significant difference ( <italic>P</italic>=0.306)
between groups.<break/> Length of hospital stay until release:
shorter in the intervention group, with significant difference (
<italic>P</italic>=0.019) between groups, if the medical
release is considered; and similar between groups, without
significant difference (<italic>P</italic>=0.552) between
groups, if non-medical factors are considered</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Franco et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, 2011</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">26 - 13/13</td><td align="left" valign="top" rowspan="1" colspan="1">BiLevel+
CP<sup>b</sup><italic>vs.</italic> CP</td><td align="left" valign="top" rowspan="1" colspan="1">IPAP: 8 to 12 cmH<sub>2</sub>O; EPAP:
6 cmH<sub>2</sub>O, 2x/day for 30 minutes</td><td align="left" valign="top" rowspan="1" colspan="1">2x/day, 2 days after surgery</td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis Length of hospital stay
until release</td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis: lower in the intervention
group, without significant difference (P=0.08) between
groups<break/> Length of hospital stay: shorter in the
intervention group (without statistically significant data)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Jousela et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, 1994</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">30 - 15/15</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP <italic>vs.</italic> oxygen
therapy</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP 7.4 cmH<sub>2</sub>O FiO<sub>2
</sub>0.3 for 8h</td><td align="left" valign="top" rowspan="1" colspan="1">FiO<sub>2</sub>0.3 for 8h</td><td align="left" valign="top" rowspan="1" colspan="1">AtelectasisPaO<sub>2</sub></td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis: similar between
groups<break/> PaO<sub>2:</sub>better in the intervention
group<sub>,</sub>with significant difference between groups
(<italic>P</italic>&#x0003c;0.05)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lopes et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, 2008</td><td align="left" valign="top" rowspan="1" colspan="1">CABG or valve surgery</td><td align="left" valign="top" rowspan="1" colspan="1">100 - 50/50</td><td align="left" valign="top" rowspan="1" colspan="1">BiLevel <italic>vs.</italic> oxygen
therapy (nasal catheter)</td><td align="left" valign="top" rowspan="1" colspan="1">For 30 minutes, IPAP for generating a
VC &#x0003e; 5 ml/kg (average value 10&#x000b1;2.12
cmH<sub>2</sub>O),&#x000a0; EPAP&#x000a0; 5 cmH<sub>2</sub>O, and oxygen
attached to the mask at 5 l/min or enough for
SpO<sub>2</sub>&#x0003e; 95%</td><td align="left" valign="top" rowspan="1" colspan="1">5 l/min</td><td align="left" valign="top" rowspan="1" colspan="1">PaO<sub>2</sub>MV Time</td><td align="left" valign="top" rowspan="1" colspan="1">PaO<sub>2</sub>: better in the
intervention group, with significant difference
(<italic>P</italic>=0.0009) between groups <break/> MV Time:
similar between groups, without significant difference (
<italic>P</italic> =0.526) between groups</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Matte et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, 2000</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">96 33,33/30</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP + CP (coughing, exercises,
aerosol therapy, mobilization) or BiLevel + CP
<italic>vs.</italic> CP + IS (volume)</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP 5 cmH<sub>2</sub>O (1h/3h);
BiLevel IPAP 12 cmH<sub>2</sub>O, EPAP 5 cmH<sub>2</sub>O
(1h/3h)</td><td align="left" valign="top" rowspan="1" colspan="1">CP parameters not described;IS 20/2
h</td><td align="left" valign="top" rowspan="1" colspan="1">AtelectasisPaO<sub>2</sub>Time spent
in the ICU</td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis: less in the intervention
group (without statistically significant data)<break/>
PaO<sub>2:</sub>increased in the intervention group, but
without significant difference <italic>P</italic>&#x0003c;0.01Time
spent in the ICU: similar, without significant difference
between groups</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mazullo, et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>, 2010</td><td align="left" valign="top" rowspan="1" colspan="1">CABG, valve replacement,Combined
surgeries, Interatrial communication, aneurysm repair</td><td align="left" valign="top" rowspan="1" colspan="1">32 - 14/18</td><td align="left" valign="top" rowspan="1" colspan="1">NIV (PSV) <italic>vs.</italic>not
described</td><td align="left" valign="top" rowspan="1" colspan="1">PSV PEEP 5 cmH<sub>2</sub>O; levels of
PSV adjusted to reach a current volume of 5 to 8 ml/kg;
FiO<sub>2</sub>40%, for 2h</td><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;Not described</td><td align="left" valign="top" rowspan="1" colspan="1">ARF after extubation</td><td align="left" valign="top" rowspan="1" colspan="1">ARF: control group presented higher
incidence. (without statistically significant data)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oikkonenet al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, 1991</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">52 - 26/26</td><td align="left" valign="top" rowspan="1" colspan="1">IPPB+CP (chest physiotherapy
techniques) <italic>vs.</italic> IS (volume) + CP</td><td align="left" valign="top" rowspan="1" colspan="1">Airway peak pressure 10 to 15
cmH<sub>2</sub>O at least four times/day, minimum of 10
satisfactory inspirations, five to 10 minutes each session</td><td align="left" valign="top" rowspan="1" colspan="1">1x/day, more frequently, if necessary
CP</td><td align="left" valign="top" rowspan="1" colspan="1">AtelectasisPaO<sub>2</sub></td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis: less in the intervention
group; without significant difference between groups
(<italic>P</italic>&#x0003e;0.1)<break/> PaO<sub>2:</sub>similar
values between groups on the first three days</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pinilla et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, 1990</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">58 - 32/26</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP+ CP (chest physiotherapy)
<italic>vs.</italic> oxygen therapy + CP</td><td align="left" valign="top" rowspan="1" colspan="1">Between 5 and 7.5 cmH<sub>2</sub>O,
for 12h</td><td align="left" valign="top" rowspan="1" colspan="1">Not described</td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis Hypoxemia
(PaO<sub>2</sub>/FiO<sub>2</sub>)Time spent in the ICU</td><td align="left" valign="top" rowspan="1" colspan="1">Atelectasis: not different between
groups <break/> Hypoxemia
(PaO<sub>2</sub>/FiO<sub>2</sub>)<sub>:</sub> significantly
improved ratio in the intervention group,
(<italic>P</italic>&#x0003c;0.05), half an hour until 24h after
extubation; after that,&#x000a0; a decrease could be noted in both
groupsTime spent in the ICU: similar between groups, without
significant difference between groups</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Thomas et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, 1992</td><td align="left" valign="top" rowspan="1" colspan="1">CABG</td><td align="left" valign="top" rowspan="1" colspan="1">28 - 14/14</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP+CP&#x000a0; <italic>vs.</italic> oxygen
therapy + CP</td><td align="left" valign="top" rowspan="1" colspan="1">5 cmH<sub>2</sub>O, for 1h</td><td align="left" valign="top" rowspan="1" colspan="1">Not described</td><td align="left" valign="top" rowspan="1" colspan="1">Hypoxemia</td><td align="left" valign="top" rowspan="1" colspan="1">Hypoxemia: significantly reduced the
pulmonary shunt in the intervention group
(<italic>P</italic>=0.016)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zarbock et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, 2009</td><td align="left" valign="top" rowspan="1" colspan="1">CABG or heart valve replacement</td><td align="left" valign="top" rowspan="1" colspan="1">468 - 232/236</td><td align="left" valign="top" rowspan="1" colspan="1">CPAP <italic>vs.</italic> standard
treatment<sup>c</sup></td><td align="left" valign="top" rowspan="1" colspan="1">10 cmH<sub>2</sub>O, for at least
6h</td><td align="left" valign="top" rowspan="1" colspan="1">Intermittent CPAP for 10 min every 4h
at 10 cm H<sub>2</sub>O; other information was not
described</td><td align="left" valign="top" rowspan="1" colspan="1">Hypoxemia (PaO<sub>2</sub>/FiO<sub>2
</sub>&#x0003c;100)Nosocomial PneumoniaReintubation rate MV TimeTime
spent in the ICU and at the hospital</td><td align="left" valign="top" rowspan="1" colspan="1">Hypoxemia
(PaO<sub>2</sub>/FiO<sub>2</sub>&#x0003c;100), pneumonia,
reintubation rate: lower in the intervention group, with
significant difference between groups
(<italic>P</italic>=0.03)<break/> MV Time late extubation group:
similar between groups, without significant difference (
<italic>P</italic>&#x0003e;0.05)Time spent in the ICU and at the
hospital:similar between groups; without significant
difference(<italic>P</italic>&#x0003e;0.05) between groups</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>CPAP: continuous positive airway pressure, MRS: myocardial
revascularization surgery, EPAP: expiratory positive airway
pressure, CP: conventional physiotherapy, I/C: intervention/control,
BMI: body mass index, IPAP: inspiratory positive airway pressure,
IPPB: intermittent positive pressure breathing, ARF: acute
respiratory failure, IS: incentive spirometer, LLs: lower limbs,
ULs: upper limbs, PaO<sub>2</sub>/FiO<sub>2</sub>: partial pressure
arterial oxygen/fraction of inspired oxygen, PEEP: Positive
end-expiratory pressure, PSV: pressure support ventilation, ICU:
intensive care unit, CV: current volume, NIV: noninvasive
ventilation, <italic>vs</italic>.: versus; usual care<sup>a</sup>:
respiratory physiotherapy, coughing exercises, IS, mobilization and
nebulization with bronchodilator (2.5 mg of salbutamol every 6
hours), with saline solution (5 mL every 6 hours); CP<sup>b</sup>:
diaphragmatic breathing exercises associated with active and/or
active-assisted movement of the LLs and ULs, clearing maneuvers,
coughing and re-expansion techniques; standard
treatment<sup>c</sup>: oxygen, CP, intermittent nasal CPAP and
pharmacological treatment.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Risk of Bias</title><p>Of all the studies included in the systematic review, 30% described the random
sequence generation<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>, 10% described allocation concealment<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>; none of the studies
described blinding of the therapist and the patient, or presented this
information; 40% of the studies described blindness of the outcome assessors,
but for only one outcome in each study<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. All studies described the losses and
exclusions<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r20" ref-type="bibr">20</xref>]</sup>, and 60% described the intention-to-treat
analysis<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup> (<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Risk of bias assessment.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Study, year</th><th align="center" rowspan="1" colspan="1">Random Sequence Generation</th><th align="center" rowspan="1" colspan="1">Allocation Concealment</th><th align="center" rowspan="1" colspan="1">Blinding&#x000a0; Therapist</th><th align="center" rowspan="1" colspan="1">Blinding&#x000a0; Patient</th><th align="center" rowspan="1" colspan="1">Blinding of the Outcome Assessment</th><th align="center" rowspan="1" colspan="1">Description of Losses and Exclusions</th><th align="center" rowspan="1" colspan="1">Intention-to-treat Analysis</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Al Jaaly et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, 2013</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes*</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Franco et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, 2011</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Jousela et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, 1994</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Lopes et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, 2008</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Matte et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, 2000</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes*</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Mazullo et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>, 2010</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Oikkonen et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, 1991</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes**</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Pinilla et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, 1990</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes**</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Thomas et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, 1992</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Zarbock et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, 2009</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Not informed</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">Yes</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Yes*=for the Atelectasis outcome; Yes**= for the chest X-ray</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Intervention Effect</title><sec><title>Mortality rate</title><p>Only one study (n=126) assessed the mortality rate. The authors compared the
use of NIV associated with usual care (chest physiotherapy, bronchodilator
and saline nebulization, cough exercises, mobilization and IS)
<italic>vs.</italic> usual care. The mortality rate was the same in both
groups (1.6%)<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p></sec></sec><sec><title>Pulmonary Complications</title><sec><title>Atelectasis</title><p>Six studies assessed the incidence of atelectasis<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Among
them, four<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup> were
included in the meta-analysis (n=407). One study compared NIV associated
with usual care <italic>vs.</italic> usual care<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>; one compared NIV associated with
conventional physiotherapy (CP) <italic>vs.</italic> CP<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>; another compared NIV
<italic>vs.</italic> oxygen therapy, exclusively<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>; another study, with two
intervention groups, compared NIV/CPAP mode associated with CP
<italic>vs.</italic> CP; and NIV/BiLevel mode associated with CP
<italic>vs.</italic> CP<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The use of NIV in the postoperative period of cardiac
surgery did not significantly reduce the risk of atelectasis (RR: 0.60,
CI95% 0.28, 1.28, I-square: 69%) (<xref ref-type="fig" rid="f2">Figure
2</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Analysis of the atelectasis regarding the studies that compared
the prophylactic NIV to the control group. NIV=noninvasive
ventilation</p></caption><graphic xlink:href="rbccv-32-04-0301-g02"/></fig>
</p><p>This high statistical heterogeneity can be explained by a study by Al Jaaly
et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, which
presented a more favorable result to the use of NIV. One of the factors that
may justify this has to do with the time of application of the therapy. The
study applied the NIV for a longer period of time, and it was withdrawn when
the patient had to eat, drink, or before if the patient could not tolerate
the ventilation support, with average application time of 16 hours. In the
other studies, the time was shorter (8 hours after extubation<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, 1h every 3h, totaling
8h<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and 2 times
a day for 30 minutes, totaling 1h<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>).</p><p>Other factors that could influence the effects of the NIV on the results are
the ventilation parameters and type of intervention performed in the control
group.</p><p>The other two studies<sup>[<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>, which were not included
in the meta-analysis due to lack of data, showed that the incidence of
atelectasis decreased at the end of the intervention with NIV, but it did
not differ from the control groups.</p></sec><sec><title>Pneumonia</title><p>Two studies<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup> assessed this outcome
(n=594). One study compared NIV associated to usual care
<italic>vs.</italic> usual care<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>; and the other, NIV <italic>vs.</italic> standard
treatment (oxygen therapy, CP, nasal intermittent CPAP for 10 min every 4h
at 10 cmH<sub>2</sub>O and pharmacological treatment)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. From the analysis, we
observed that the use of NIV did not significantly reduce the probability of
pneumonia (RR: 0.20; CI95% 0.04; 1.16; I-square: 0%) (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Analysis of the pneumonia regarding the studies that compared the
prophylactic NIV to the control group. NIV=noninvasive
ventilation</p></caption><graphic xlink:href="rbccv-32-04-0301-g03"/></fig></p></sec><sec><title>Acute Respiratory Failure</title><p>Only one study assessed this outcome. Mazzulo Filho et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> carried out a study with
32 patients during the immediate postoperative period of cardiac surgery.
The patients were randomly divided into two groups: control (n=18) and
intervention (n=14), which received NIV/PSV mode during 2 hours, after
extubation. As to the pulmonary complication, none of the patients from the
intervention group presented ARF; on the other hand, nine patients from the
control group did.</p></sec><sec><title>Hypoxemia</title><p>Three studies<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup> assessed this outcome. It was impossible to
perform the meta-analysis of this outcome, because the studies did not
present sufficient data for the analysis.</p><p>Zarbock et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>
performed a study with 468 patients that underwent elective heart surgery,
and compared the NIV/CPAP mode <italic>vs.</italic> standard treatment
(oxygen therapy, CP, nasal intermittent CPAP for 10 min every 4h at 10
cmH<sub>2</sub>O and pharmacological treatment). The study showed that
the incidence of hypoxemia (PaO<sub>2</sub>/FiO<sub>2</sub>&#x0003c; 100) was
lower in the intervention group, when compared with the control group (1 of
232; 5 of 236 patients, respectively).</p><p>Pinilla et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> carried
out a study with 58 patients, and compared NIV/CPAP mode associated to CP
<italic>vs.</italic> CP and oxygen therapy. They found that the
PaO<sub>2</sub>/FiO<sub>2</sub> ratio was significantly better in the
intervention group (<italic>P</italic>&#x0003c;0.05), half an hour until 24h
after extubation, when compared with the control group; after that, it
decreased in both groups (325&#x000b1;62, 320&#x000b1;37, in the intervention
and control groups, respectively, without difference between groups).</p><p>Thomas et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> compared
two groups with 14 patients after CABG, applying NIV/CPAP mode associated to
CP <italic>vs.</italic> CP and oxygen therapy. The fraction of the pulmonary
shunt was of 16.3% before, 12.6% during and 15.7% after the CPAP; in the
control group, the shunt was reduced from 17.3% to 16.8%. This reduction was
significantly higher in the CPAP group when compared with the control group
(<italic>P</italic>=0.016).</p></sec></sec><sec><title>PaO<sub>2</sub></title><p>Four studies<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup> assessed this outcome. It was
not possible to perform the meta-analysis of this outcome, because the studies
did not present sufficient data for the analysis.</p><p>Matte et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> performed a
study with 96 patients, randomly divided into three groups. The study assessed
two intervention groups: one group compared NIV/CPAP mode associated to CP
(coughing, aerosol therapy, exercises, mobilization) <italic>vs.</italic> CP,
and the other compared NIV/BiLevel mode associated to CP <italic>vs.</italic>
CP. In the three groups, the PaO<sub>2</sub> (mmHg) significantly decreased in
the 1<sup>st</sup> day of postoperative care (preoperative: control group
78&#x000b1;10, CPAP 76&#x000b1;12, BiLevel 81&#x000b1;10; 1<sup>st</sup> day before
treatment: control group 65&#x000b1;12, CPAP 63&#x000b1;9, BiLevel 66 &#x000b1;11;
<italic>P</italic>&#x0003c;0.001). For the patients of the control group, this
decrease was still present on the 2<sup>nd</sup> day; however, the patients in
the intervention group presented a slightly improved PaO<sub>2</sub>
(<italic>P</italic>&#x0003c;0.01).</p><p>Lopes et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> developed a
study with 100 patients that underwent CABG or heart valve surgery, randomly
divided into two groups. The study applied NIV/BiLevel mode for 30 minutes after
extubation <italic>vs.</italic> oxygen therapy. The NIV improved the
PaO<sub>2</sub>, with significant difference (<italic>P</italic>=0.0009)
between groups; the same happened with time, comparing the moment before
extubation with 30, 120 and 360 minutes after the procedure
(<italic>P</italic>=0.00008)<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Conversely, two studies<sup>[<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup> found different results. In a
study performed with 30 patients that underwent CABG, who were randomly divided
into two groups, NIV/CPAP mode <italic>vs.</italic> oxygen therapy, the
PaO<sub>2</sub> decreased significantly in the control group after
extubation (from 19.2&#x000b1;5.3 kPa to 12.4&#x000b1;2.7 kPa), but it decreased
less in the CPAP group (from 16.4&#x000b1;3.3 kPa to 14.0&#x000b1;2.1kPa). In the
2<sup>nd</sup> PO, the PaO<sub>2</sub> was equally low in both groups
(control: 8.4&#x000b1;1.5 kPa, CPAP: 8.9&#x000b1;1.9 kPa)<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>Oikkonen et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> performed a
study with 52 patients who were randomly divided into two groups: IPPB
associated to CP <italic>vs.</italic> CP and IS. On the first three days of PO
care, the values of PaO<sub>2</sub> (kPa) were similar in both groups
(1<sup>st</sup> PO: control 14&#x000b1;1, IPPB 15&#x000b1;1; 2<sup>nd</sup>
PO: control 12&#x000b1;1, IPPB 11 &#x000b1; 1; 3<sup>rd</sup> PO: control
10&#x000b1;1, IPPB 11&#x000b1;1), without statistically significant differences.
Based on this, both resources are equally efficient.</p></sec><sec><title>Reintubation Rate</title><p>Two studies assessed this outcome (n= 594)<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. It was
observed that using NIV does not significantly reduce the probability of
reintubation (RR: 0.51; CI95%: 0.15; 1.66; I-square: 0%) (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Analysis of the reintubation rate regarding the studies that compared
the prophylactic NIV to the control group. NIV=noninvasive
ventilation</p></caption><graphic xlink:href="rbccv-32-04-0301-g04"/></fig></p></sec><sec><title>Time spent in the ICU</title><p>Three studies assessed this outcome (n=641)<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>. One study assessed two
intervention groups: one compared NIV/CPAP mode associated to CP
<italic>vs.</italic> CP, and the other compared NIV/BiLevel mode associated
to CP <italic>vs.</italic> CP<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Another study compared NIV associated to CP
<italic>vs.</italic> oxygen therapy associated to CP<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>; and another study assessed
NIV <italic>vs.</italic> standard treatment<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. It was observed that using NIV does not significantly
reduce the time spent in the ICU (-0.04 days; CI95%: - 0.13; 0.05; I-square: 0%)
(<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Analysis of the time spent in the intensive care unit regarding the
studies that compared the prophylactic NIV to the control group.
NIV=noninvasive ventilation.</p></caption><graphic xlink:href="rbccv-32-04-0301-g05"/></fig></p></sec><sec><title>Length of Hospital Stay</title><p>Only two studies assessed length of hospital stay (n=594)<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>, however, it was not possible to perform the
meta-analysis due to lack of data. According to Al Jaaly et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, the length of hospital stay
until release from hospital care, in days, was shorter in the intervention
group, when compared with the control group (5&#x000b1;1.5; 6&#x000b1;1.5,
respectively, <italic>P</italic>=0.019). Considering only the doctors' opinion,
the patients could be released. However, because of non-medical reasons (such as
social factors), the patients could not be released and the total length of
hospital stay until the release was similar, without significant difference
between groups (<italic>P</italic>=0.552).</p><p>A study by Zarbock et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>
showed that the total length of hospital stay was similar between groups,
without significant difference (intervention group 13&#x000b1;0.5 days, control
group 14&#x000b1;0.6 days; <italic>P</italic>&#x0003e;0.05).</p></sec><sec><title>Mechanical Ventilation Time</title><p>Three studies assessed this outcome (n=694)<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>; however, it was not possible
to perform the meta-analysis due to lack of data.</p><p>In the study by Lopes et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>,
comparing NIV <italic>vs.</italic> oxygen therapy, the average time of
mechanical ventilation was 3.77&#x000b1;0.94h, with no significant difference
between the control and intervention groups (<italic>P</italic>=0.526). Zarbock
et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> assessed NIV
<italic>vs.</italic> standard treatment after admission to the ICU. The
patients were divided into two groups: the late extubated group and the
extubated group; after that, each group was subdivided into intervention and
control groups. Patients in the late extubated group (intervention and control)
were ventilated for the same length of time (6.2&#x000b1;0.5 h, 6.&#x000b1;0.7 h,
respectively, <italic>P</italic>&#x0003e;0.05); data from the extubated group were
not described. Finally, the third study assessed NIV associated with usual care
<italic>vs.</italic> usual care, and the average time was 6 hours for the
intervention and control groups<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><sec><title>Evidence Summary</title><p>The objective of this study was to search for the best available scientific
evidence regarding the prophylactic use of NIV in patients during immediate
postoperative care for cardiac surgery. Regarding the mortality rate, only one
study assessed this outcome, and the result was similar between the intervention
and control groups. We observed that prophylactic NIV, when compared to
conventional physiotherapy or oxygen therapy, did not significantly reduce the
probability of pulmonary complications such as atelectasis, pneumonia,
reintubation rate and time spent in the ICU. As to the outcome of ARF, the
incidence was higher in the control group. Regarding the outcome of hypoxemia,
in most studies, the use of NIV improved oxygenation. Regarding PaO<sub>2</sub>,
only half of the studies that assessed this outcome found that NIV improved it.
As to the mechanical ventilation time and length of hospital stay, the results
were similar between the groups.</p><p>For the outcome mortality rate, study showed low incidence between the
intervention and control groups. This can be explained by the fact that the
patients included in the studies had preoperative comorbidities, and similar
surgical characteristics, among others, without the need for emergency
surgery<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>. However,
more studies should be carried out to expand this information.</p><p>Another outcome assessed by our study was pulmonary complications. These are
frequent in the PO of cardiac surgery, and the etiology of the dysfunction
results from a multifactorial process, which involves surgical and preoperative
factors, well reported in the literature<sup>[<xref rid="r4" ref-type="bibr">4</xref>-<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Thus, early
therapy is necessary to avoid further degradation<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>From the review, it was observed that using NIV during the postoperative care of
heart surgery did not significantly reduce the risk of atelectasis, but it
improved oxygenation. This complication is often caused by a compromised
ventilation lung perfusion ratio due to atelectasis. Even after cardiac surgery
without complications, atelectatic areas decrease functional residual capacity
and increase pulmonary shunt. These unventilated areas can account for up to 20%
of the total lung volume, thus causing hypoxemia in the PO<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. In this sense, NIV avoids
alveolar collapse and enables better alveolar recruitment, reducing the
formation of atelectasis and increasing functional residual capacity<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>.</p><p>Even though NIV presents positive effects in other populations, such as patients
with ARF in the postoperative period of abdominal surgery<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>, in our study we have not yet
found a beneficial effect of this intervention in relation to atelectasis. One
thing that may justify these unfavorable outcomes are the NIV pressure
parameters, with CPAP values between 5 and 7.5 cmH<sub>2</sub>O<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>. These pressures low in the airways have transitory
effects on gas exchange<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>. It is believed that, for a
prolonged effect, high pressure values are required to keep airways
open<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. A previous
study performed with patients after thoracic surgery demonstrated that pressures
of at least 9 to 10 cmH<sub>2</sub>O should be used to maintain positive
tracheal pressure throughout the respiratory cycle<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>Another pulmonary complication is pneumonia. From the analysis, it was observed
that using NIV did not significantly reduce the probability of
pneumonia<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. We observed that there is a
favorable tendency to the use of NIV; however, more RCTs, with larger sample
sizes, are necessary to corroborate this information.</p><p>Regarding the outcomes of reintubation rate and time spent in the ICU, it was
observed that using NIV does not significantly reduce the probability of
reintubation and the time spent in the ICU. This may have occurred because of
the small number of included studies (two and three, respectively). It is
possible that with more RCTs, with larger sample sizes, this result could
change; therefore, there is no evidence on the effectiveness of NIV on the
reintubation rate and time spent in the ICU.</p><p>Another assessed outcome was the length of hospital stay, but only two studies
assessed it<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. The time was similar between groups in both
studies, with no significant difference between groups. This similarity can be
justified by the low incidence of pulmonary complications in both studies, which
could prolong this time if an increase occurred.</p></sec><sec><title>The Strengths and Limitations of the Study</title><p>Regarding the strong methodological points of this study, it is important to
point out the systematic and sensitive bibliographic search, with explicit and
reproducible eligibility criteria, without restriction of language and date,
independently performed by two assessors; as well as the selection of studies,
data extraction and analysis of methodological quality of included articles,
also performed independently by two assessors. In addition to that, a
meta-analysis was performed with the results of the studies, provided they
allowed such analysis, since the meta-analysis can give more reliable estimates
as to the efficacy of the treatment.</p><p>As to the limitations, the low methodological quality of the included studies
stands out, since the indispensable items for assessing the risk of bias were
presented incompletely or not informed. In addition, the included studies were
quite different regarding the physiotherapy techniques, resources and exercises
used, time of intervention, time of application of NIV and frequency of
examinations. All this may compromise the results found in the
meta-analyses.</p><p>In addition to the methodological differences, we highlight the small number of
studies found in the literature, and the sample size, with small number of
patients, which suggest the need for new RCTs with more patients and more
methodological rigor.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Our study showed that no difference between the use of prophylactic NIV and
conventional physiotherapy or oxygen therapy could be found in patients during the
postoperative period of cardiac surgery, in relation to mortality rate and pulmonary
complications such as atelectasis, pneumonia, reintubation rate, time spent in the
ICU, length of hospital stay and mechanical ventilation time, with an improvement in
oxygenation. Therefore, due to the low methodological rigor of the included articles
and small sample size, new RCTs should be carried out to corroborate this
information.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">SMP</td><td align="left" valign="top" rowspan="1" colspan="1">Conception and design of the work;
acquisition, analysis, interpretation of data for the work; drafting
the work and revising it critically for important intellectual
content; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AGFM</td><td align="left" valign="top" rowspan="1" colspan="1">Conception and design of the work;
acquisition, analysis, interpretation of data for the work; drafting
the work and revising it critically for important intellectual
content; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GS</td><td align="left" valign="top" rowspan="1" colspan="1">Conception and design of the work;
acquisition, analysis, interpretation of data for the work; drafting
the work and revising it critically for important intellectual
content; final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Multi-professional Integrated Residency in
Health and Cardiovascular Care of the Hospital de Cl&#x000ed;nicas of Porto
Alegre (HCPA), Porto Alegre, RS, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Chevallard</surname><given-names>G</given-names></name><name><surname>Gregoretti</surname><given-names>C</given-names></name></person-group><article-title>Non-invasive ventilation in postoperative patients: a systematic
review</article-title><source>Intensive Care Med</source><year>2011</year><volume>37</volume><issue>6</issue><fpage>918</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">21424246</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niyayeh Saffari</surname><given-names>NH</given-names></name><name><surname>Nasiri</surname><given-names>E</given-names></name><name><surname>Mousavinasab</surname><given-names>SN</given-names></name><name><surname>Ghafari</surname><given-names>R</given-names></name><name><surname>Soleimani</surname><given-names>A</given-names></name><name><surname>Esmaeili</surname><given-names>R</given-names></name></person-group><article-title>Frequency rate of atelectasis in patients following coronary
artery bypass graft and its associated factors at Mazandaran Heart Center in
2013-2014</article-title><source>Glob J Health Sci</source><year>2015</year><volume>7</volume><issue>7 Spec No</issue><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">26153209</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matte</surname><given-names>P</given-names></name><name><surname>Jacquet</surname><given-names>L</given-names></name><name><surname>Van Dyck</surname><given-names>M</given-names></name><name><surname>Goenen</surname><given-names>M</given-names></name></person-group><article-title>Effects of conventional physiotherapy, continuous positive airway
pressure and non-invasive ventilatory support with bilevel positive airway
pressure after coronary artery bypass grafting</article-title><source>Acta Anaesthesiol Scand</source><year>2000</year><volume>44</volume><issue>1</issue><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10669276</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissman</surname><given-names>C</given-names></name></person-group><article-title>Pulmonary complications after cardiac surgery</article-title><source>Semin Cardiothorac Vasc Anesth</source><year>2004</year><volume>8</volume><issue>3</issue><fpage>185</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">15375480</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchesa</surname><given-names>CA</given-names></name><name><surname>Greca</surname><given-names>FH</given-names></name><name><surname>Guarita-Souza</surname><given-names>LC</given-names></name><name><surname>Santos</surname><given-names>JLV</given-names></name><name><surname>Aquim</surname><given-names>EE</given-names></name></person-group><article-title>Papel da eletroanalgesia na fun&#x000e7;&#x000e3;o
respirat&#x000f3;ria de pacientes submetidos &#x000e0; opera&#x000e7;&#x000e3;o
de revasculariza&#x000e7;&#x000e3;o do mioc&#x000e1;rdio</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>3</issue><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">20011888</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffmyer</surname><given-names>JL</given-names></name><name><surname>Groves</surname><given-names>DS</given-names></name></person-group><article-title>Pulmonary complications of cardiopulmonary bypass</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2015</year><volume>29</volume><issue>2</issue><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">26060028</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laizo</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>FEF</given-names></name><name><surname>Rocha</surname><given-names>GM</given-names></name></person-group><article-title>Complica&#x000e7;&#x000f5;es que aumentam o tempo de
perman&#x000ea;ncia na unidade de terapia intensiva na cirurgia
card&#x000ed;aca</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>2</issue><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">20802907</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>CR</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>CMA</given-names></name><name><surname>Nozawa</surname><given-names>E</given-names></name><name><surname>Auler Junior</surname><given-names>JOC</given-names></name></person-group><article-title>Benef&#x000ed;cios da ventila&#x000e7;&#x000e3;o n&#x000e3;o-invasiva
ap&#x000f3;s extuba&#x000e7;&#x000e3;o no p&#x000f3;s-operat&#x000f3;rio de
cirurgia card&#x000ed;aca</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>344</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">19082322</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaber</surname><given-names>S</given-names></name><name><surname>Chanques</surname><given-names>G</given-names></name><name><surname>Jung</surname><given-names>B</given-names></name></person-group><article-title>Postoperative noninvasive ventilation</article-title><source>Anesthesiology</source><year>2010</year><volume>112</volume><issue>2</issue><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">20068454</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Mueller</surname><given-names>E</given-names></name><name><surname>Netzer</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>A</given-names></name><name><surname>Feindt</surname><given-names>P</given-names></name><name><surname>Kindgen-Milles</surname><given-names>D</given-names></name></person-group><article-title>Prophylactic nasal continuous positive airway pressure following
cardiac surgery protects from postoperative pulmonary complications: a
prospective, randomized, controlled trial in 500 patients</article-title><source>Chest</source><year>2009</year><volume>135</volume><issue>5</issue><fpage>1252</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">19017864</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jousela</surname><given-names>I</given-names></name><name><surname>R&#x000e4;s&#x000e4;nen</surname><given-names>J</given-names></name><name><surname>Verkkala</surname><given-names>K</given-names></name><name><surname>Lamminen</surname><given-names>A</given-names></name><name><surname>M&#x000e4;kel&#x000e4;inen</surname><given-names>A</given-names></name><name><surname>Nikki</surname><given-names>P</given-names></name></person-group><article-title>Continuous positive airway pressure by mask in patients after
coronary surgery</article-title><source>Acta Anaesthesiol Scand</source><year>1994</year><volume>38</volume><issue>4</issue><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">8067215</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><collab>PRISMA Group</collab></person-group><article-title>Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement</article-title><source>BMJ</source><year>2009</year><volume>339</volume><comment>b2535</comment></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><article-title>Cochrane handbook for systematic reviews of
interventions</article-title><edition>Version 5.3.0</edition><date-in-citation content-type="access-date">October 2015</date-in-citation><source>The Cochrane Collaboration</source><year>2015</year></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>KA</given-names></name><name><surname>Dickersin</surname><given-names>K</given-names></name></person-group><article-title>Development of a highly sensitive search strategy for the
retrieval of reports of controlled trials using PubMed</article-title><source>Int J Epidemiol</source><year>2002</year><volume>31</volume><issue>1</issue><fpage>150</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">11914311</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Jaaly</surname><given-names>E</given-names></name><name><surname>Fiorentino</surname><given-names>F</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Ind</surname><given-names>PW</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Kemp</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of adding postoperative noninvasive ventilation to usual
care to prevent pulmonary complications in patients undergoing coronary
artery bypass grafting: a randomized controlled trial</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>146</volume><issue>4</issue><fpage>912</fpage><lpage>918</lpage><pub-id pub-id-type="pmid">23582830</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>AM</given-names></name><name><surname>Torres</surname><given-names>FC</given-names></name><name><surname>Simon</surname><given-names>IS</given-names></name><name><surname>Morales</surname><given-names>D</given-names></name><name><surname>Rodrigues</surname><given-names>AJ</given-names></name></person-group><article-title>Assessment of noninvasive ventilation with two levels of positive
airway pressure in patients after cardiac surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2011</year><volume>26</volume><issue>4</issue><fpage>582</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">22358273</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinilla</surname><given-names>JC</given-names></name><name><surname>Oleniuk</surname><given-names>FH</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Rebeyka</surname><given-names>I</given-names></name><name><surname>Tanna</surname><given-names>N</given-names></name><name><surname>Wilkinson</surname><given-names>A</given-names></name><etal/></person-group><article-title>Use of a nasal continuous positive airway pressure mask in the
treatment of postoperative atelectasis in aortocoronary bypass
surgery</article-title><source>Crit Care Med</source><year>1990</year><volume>18</volume><issue>8</issue><fpage>836</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">2199148</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>AN</given-names></name><name><surname>Ryan</surname><given-names>JP</given-names></name><name><surname>Doran</surname><given-names>BR</given-names></name><name><surname>Pollard</surname><given-names>BJ</given-names></name></person-group><article-title>Nasal CPAP after coronary artery surgery</article-title><source>Anaesthesia</source><year>1992</year><volume>47</volume><issue>4</issue><fpage>316</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">1519683</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikkonen</surname><given-names>M</given-names></name><name><surname>Karjalainen</surname><given-names>K</given-names></name><name><surname>K&#x000e4;h&#x000e4;r&#x000e4;</surname><given-names>V</given-names></name><name><surname>Kuosa</surname><given-names>R</given-names></name><name><surname>Schavikin</surname><given-names>L</given-names></name></person-group><article-title>Comparison of incentive spirometry and intermittent positive
pressure breathing after coronary artery bypass graft</article-title><source>Chest</source><year>1991</year><volume>99</volume><issue>1</issue><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">1984988</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzulo Filho</surname><given-names>JBR</given-names></name><name><surname>Bonfim</surname><given-names>VJG</given-names></name><name><surname>Aquim</surname><given-names>EE</given-names></name></person-group><article-title>Ventila&#x000e7;&#x000e3;o mec&#x000e2;nica n&#x000e3;o invasiva no
p&#x000f3;s-operat&#x000f3;rio imediato de cirurgia
card&#x000ed;aca</article-title><source>Rev Bras Ter Intensiva</source><year>2010</year><volume>22</volume><issue>4</issue><fpage>363</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">25302513</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Associa&#x000e7;&#x000e3;o de Medicina Intensiva Brasileira
(AMIB)</collab><collab>Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)</collab></person-group><source>Diretrizes brasileiras de ventila&#x000e7;&#x000e3;o mec&#x000e2;nica -
2013</source><ext-link ext-link-type="uri" xlink:href="http://itarget.com.br/newclients/sbpt.org.br/2011/downloads/arquivos/Dir_VM_2013/Diretrizes_VM2013_SBPT_AMIB.pdf">http://itarget.com.br/newclients/sbpt.org.br/2011/downloads/arquivos/Dir_VM_2013/Diretrizes_VM2013_SBPT_AMIB.pdf</ext-link></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kindgen-Milles</surname><given-names>Buhl R</given-names></name><name><surname>Loer SA</surname><given-names>M&#x000fc;ller E</given-names></name></person-group><article-title>Nasal CPAP therapy: effects of different CPAP levels on pressure
transmission into the trachea and pulmonary oxygen transfer</article-title><source>Acta Anaesthesiol Scand</source><year>2002</year><volume>46</volume><issue>7</issue><fpage>860</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">12139543</pub-id></element-citation></ref></ref-list></back></article>